These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 8095550

  • 1. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G, Robertson GS, Tham CS, Fibiger HC.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [Abstract] [Full Text] [Related]

  • 3. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
    Ackerman JM, Johansen PA, Clark D, White FJ.
    J Pharmacol Exp Ther; 1993 May; 265(2):963-70. PubMed ID: 8098768
    [Abstract] [Full Text] [Related]

  • 5. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S, Johansson B, Fredholm BB.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [Abstract] [Full Text] [Related]

  • 6. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E, Wilson C, Fibiger HC.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
    [Abstract] [Full Text] [Related]

  • 7. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG, Vizi ES.
    Pol J Pharmacol Pharm; 1985 Apr; 37(3):383-96. PubMed ID: 2866504
    [Abstract] [Full Text] [Related]

  • 8. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H, Lovenberg T, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [Abstract] [Full Text] [Related]

  • 9. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS, Talmaciu RK, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E, Tonello C, Imhof R, Scherschlicht R, da Prada M, Carruba MO.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [Abstract] [Full Text] [Related]

  • 11. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [Abstract] [Full Text] [Related]

  • 12. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ, Randall S, Chase TN.
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [Abstract] [Full Text] [Related]

  • 13. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 14. [Chronic treatment with nicotine enhances the sensitivity of dopamine autoreceptors that modulate dopamine release from the rat striatum].
    Takaki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):335-44. PubMed ID: 7584728
    [Abstract] [Full Text] [Related]

  • 15. The dopaminergic actions of B-HT 920.
    Kulkarni SK, Chopra K.
    Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):99-102. PubMed ID: 1969506
    [Abstract] [Full Text] [Related]

  • 16. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [Abstract] [Full Text] [Related]

  • 17. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 18. [Selective analyzers of dopamine D2 receptors modulate serotonin metabolism in the striatum and nucleus accumbens of the rat brain during blockade of dopaminergic impulse flow].
    Gaĭnetdinov RR, Bogdanov MB, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1992 Jun; 113(6):614-6. PubMed ID: 1359911
    [Abstract] [Full Text] [Related]

  • 19. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M, White FJ.
    Synapse; 1989 Jun; 4(4):267-80. PubMed ID: 2603146
    [Abstract] [Full Text] [Related]

  • 20. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
    Foreman MM, Fuller RW, Hynes MD, Gidda JS, Nichols CL, Schaus JM, Kornfeld EC, Clemens JA.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):227-35. PubMed ID: 2526214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.